vivoPharm Competitors and Similar CompaniesClear all
vivoPharm's competitors and similar companies include Curasight and Microvascular Therapeutics.
 Curasight Curasight is a company engaged in the field of exploiting a Positron Emissions Tomography (PET) imaging platform targeting the urokinase-type plasminogen activator receptor (uPAR). |  Microvascular Therapeutics Microvascular Therapeutics (MVT) is a biotechnology company engaged in the development of an ultrasound contrast agent, MVT-100. | ||
Founding Date | Founding Date 2003 | Founding Date 2013 | Founding Date 2016 |
Type | Type Subsidiary | Type Private | Type Private |
Tags | |||
Locations | Locations Bundoora, AU HQ München, DE Hummelstown, US | Locations København, DK HQ | Locations Tucson, US HQ |
Employees | Employees 20 | Employees 7 | Employees 1220% increase |
For sources of this data, please see the company profile
View Company Profiles
Curasight
HQ
København, DK
Employees
7
Curasight is a company engaged in the field of exploiting a Positron Emissions Tomography (PET) imaging platform targeting the urokinase-type plasminogen activator receptor (uPAR).
View companyMicrovascular Therapeutics
HQ
Tucson, US
Employees
12↑ 20% increase
Microvascular Therapeutics (MVT) is a biotechnology company engaged in the development of an ultrasound contrast agent, MVT-100.
View company